Skip to main content

Table 4 Showing the sites of distant metastases by CT versus PET-CT

From: The added value of18F-FDG PET/CT in staging non-small cell lung cancer

 CTPETP. diff.P. agree.Kappa
No.%No.%
Contalateral nodulesPositive922.537.50.0600.0010.437 (0.0932 to 0.780)
Negative3177.53792.5
Pleural effusionPositive1025.037.50.0340.0830.217 (− 0.0999 to 0.535)
Negative3075.03792.5
Liver metsPositive717.5512.50.5310.0000.805 (0.546 to 1.000)
Negative3382.53587.5
Adrenal metsPositive37.5410.00.6920.0000.844 (0.545 to 1.000)
Negative3792.53690.0
Bone metsPositive717.51332.50.1210.0000.612 (0.348 to 0.876)
Negative3382.52767.5
Intramuscular metsPositive12.5410.00.1660.0020.375 (− 0.156 to 0.906)
Negative3997.53690.0
Brain metsPositive25.025.01.0000.0001.000 (1.000 to 1.000)
Negative3895.03895.0
Abdominal LNsPositive37.5717.50.1760.0000.553 (0.181 to 0.925)
Negative3792.53382.5
Pancreatic metsPositive12.512.51.0000.0001.000 (1.000 to 1.000)
Negative3997.53997.5